Open AccessEffect of Fluticasone 250 μg/salmeterol 50 μg and Montelukast on Exhaled Nitric Oxide in Asthmatic Patients
Author(s) -
Arthur F. Gelb,
Colleen Flynn Taylor,
Chris M. Shinar,
Carlos Cano,
Noé Zamel
Publication year - 2008
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2008/415391
Subject(s) - medicine , exhaled nitric oxide , montelukast , spirometry , fluticasone , asthma , salmeterol , vital capacity , anesthesia , bronchodilator , gastroenterology , corticosteroid , lung , lung function , diffusing capacity
Monitoring noninvasive biomarkers of inflammation is an important adjunct in asthma therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom